Delivery Order SPE2D021D0005-SPE2D326F117U

Genentech USA, Inc., a foreign-owned pharmaceutical manufacturer headquartered in South San Francisco, California, received a $45.1 million delivery order from the Office of the Assistant Secretary for Preparedness and Response (ASPR) for Oseltamivir Phosphate (Tamiflu) 30mg and 75mg capsules. Awarded on January 30, 2025, with an ultimate completion date of June 6, 2025, this firm fixed-price contract utilizes no set-aside designation and is issued under Genentech's existing Pharmaceuticals...

The Defense Logistics Agency Troop Support Medical awarded a $150,743.97 firm-fixed-price delivery order to Genentech USA, Inc. for the pharmaceutical product oseltamivir phosphate. Genentech is a foreign-owned, for-profit manufacturer of biologics, including antiviral medications like Tamiflu. The contract has a completion date of September 10, 2018 and was awarded on September 8, 2017. This order was placed against one of Genentech's existing indefinite delivery contracts or Federal Supply...

The Defense Logistics Agency Troop Support Medical awarded a $343,886.48 firm fixed-price delivery order contract to Genentech USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer. This order is placed under an existing contract vehicle and supports the agency's requirement for pharmaceutical products. Genentech holds various indefinite delivery contracts and Federal Supply Schedule agreements with government agencies, allowing them to efficiently procure vital medicines like the...

This $342,870.90 firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Genentech USA, Inc., a biotechnology company that manufactures pharmaceuticals. The contract is for the antiviral drug oseltamivir phospha and does not utilize any set-aside designation. Genentech has provided a variety of biologic medicines to government agencies through multiple federal contract vehicles, including the Pharmaceuticals and Drugs Federal Supply Schedule. This...

<p>The Defense Logistics Agency, on behalf of the Medical Supply Chain, issued a $3,798.50 delivery order to Amerisourcebergen Drug Corp on May 30, 2024, for oseltamivir phosphate with an ultimate completion date of June 27, 2024.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside applied.</p>

The Defense Logistics Agency Troop Support Medical awarded a $228,798.54 firm-fixed-price delivery order contract to Genentech USA, Inc. for the procurement of the antiviral medication oseltamivir phosphate. As a prime contractor, Genentech, a foreign-owned, for-profit manufacturer of pharmaceuticals, will deliver the drug to support the agency's medical mission. The agency did not use a set-aside for this contract. Genentech has previously provided various biologic medicines, including...

<p>The Defense Logistics Agency issued a $15,490.50 delivery order to Amerisourcebergen Drug Corp on May 4, 2026, for Oseltamivir Phosphate 75 mg capsules under a firm fixed-price arrangement.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of May 5, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $1,613.63 delivery order to Amerisourcebergen Drug Corp on April 29, 2026, for oseltamivir phosphate 75 mg capsules (100-count).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of April 30, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a $1,363.42 delivery order to Amerisourcebergen Drug Corp on April 23, 2026, for oseltamivir phosphate 75 mg capsules under a firm fixed-price arrangement. The order is placed against a single-award indefinite delivery contract with the Defense Logistics Agency valued at $4.999 million through December 2036, supporting the Pharmaceutical Prime Vendor Global Program Generation V for military healthcare supply. Place of performance is Conshohocken, PA. The order...

<p>The Defense Logistics Agency issued a $5,111.78 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Oseltamivir Phosphate 75 mg capsules (unit dose, 10-count).</p> <p>Place of performance is Conshohocken, PA. The order ceiling value is $5,111.78 with an ultimate completion date of February 10, 2026. Pricing is firm fixed price. No set-aside was used.</p>